Pete Latham, M.S., PgMP

Peter Latham is Founder and President of Latham BioPharm Group (LBG), a consulting firm with expertise in the formation of product development teams and the funding and management of Life Science programs. Dr. Latham brings deep industry knowledge and skills to both government and commercially-funded biodefense, infectious diseases and pandemic response programs. He has thirty years of experience in general management with over twenty years specializing in financial, strategic, program management, and business development consulting. Dr. Latham has successfully managed multiple government programs and remains actively engaged in biodefense and pandemic response, having served as Systems Integrator for DOD and HHS programs. Dr. Latham earned his M.S., Management from MIT Sloan School of Management.